The Koba coast sits at the edge of Boké Prefecture, in northwestern Guinea, where the Guinea Current — one of the Atlantic's most productive upwelling systems — presses cold, phosphate-rich water against a shoreline that very few researchers visit. The coastal intertidal zone here is dense, layered, and largely undocumented. We were there on a sourcing expedition in the spring. What we brought back from the tidal shallows is in analysis.
"The ocean keeps its rarest things in the places no one thought to look."
What the Guinea Current makes possible
The Guinea Current Large Marine Ecosystem covers 580,000 square kilometres of coastal and open Atlantic water. Its upwelling mechanism draws phosphates and nitrates to the surface in concentrations that sustain extraordinary marine life. For algae in particular, this is not a monoculture — it is a competition, dozens of species occupying the shallows at different depths, different tidal windows, different salinities. The Koba shore, at low tide on an overcast morning, reads like a single page from a very long book.
The specimen we collected is a red macroalgae. Its habit — the physical structure and pattern of its growth on rock — matches nothing in our reference library. That alone does not make it new. The Atlantic West Africa coastline is dramatically under-surveyed; absence from a published database is not the same as absence of prior documentation. But four months in, our analytical partners in Grasse have not found a match across three separate databases. The conversation is still opening, not closing.
Why we wait before we claim anything
Novelty in marine biology is a precise term. A specimen is new only once its genome sequence, morphology, and ecological context have been formally compared against the full published literature — a process that takes months, sometimes years. The 2025 Tara Oceans study, which processed samples collected across a decade of ocean expeditions, identified a previously unknown deep-branching lineage of nano-size algae, informally named leptophytes, that had escaped scientific notice despite being globally distributed. Discovery at that scale is not dramatic. It is slow, collaborative, and nearly always revised several times before anything is declared. We have no intention of declaring this find new until the work says so. We are patient with science the way we are patient with a numbered batch.
What the first round of analysis found
What we can say from the first extraction pass: the specimen contains a measurable concentration of sulphated polysaccharides — the same compound class found in fucoidan, the brown algae active associated with anti-inflammatory and barrier-support properties in skin. The phytochemical profile is coherent with bioactive potential. Whether the concentrations, stability, and safety profile are sufficient for formulation is a separate question, and that work is ongoing.
We formulate conservatively. We do not introduce an active until we can name its origin, its mechanism, and its track record across enough controlled exposure to trust it. If this algae resolves to a known species with a different morphology, and its compounds match what we already source through more established partnerships, we may still decide not to use it — because the supply chain from a remote coastline that receives very little scientific traffic is not yet a supply chain we can stand behind.
We will write again when the analysis resolves — whether that points toward formulation, or simply toward a better understanding of what grows at the edge of an Atlantic shore that deserved serious study long before we arrived there. The Koba coast is not a secret. It is simply one of those places that science has been slow to reach. Members of the Honoured List who reserve from the next numbered batch will be the first to hear what the lab decides.
— with care.